A comparison between the effects of Portulaca oleracea seeds extract and valsartan on echocardiographic and hemodynamic parameters in rats with levothyroxine-induced thyrotoxicosis

Document Type : Original Research Article


1 Department of Physiology, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran

2 Department of Physiology and Cardiovascular Research Center, School of Medicine Mashhad University of Medical Sciences Mashhad, Iran

3 Cardiology Department, Ghaem Hospital, Mashhad University of Medical Sciences, Mashhad, Iran

4 Department of pharmacology, faculty of medicine, Mashhad university of medical sciences,Mashhad,Iran

5 Pharmacological Research Center of Medicinal Plants, Department of Pharmacology, Faculty of Medicine, Mashhad University of Medical Sciences


Objective: The aim of the present study was to compare the effects of Portulaca oleracea (Po) seeds extract and those of valsartan on cardiac function in levothyroxine (T4)-treated rats.
Materials and Methods: Forty Wistar rats were divided into four groups (n=10): control, levothyroxine (T4), T4 plus valsartan (T4-Val) and T4 plus hydro-alcoholic extract of the P. oleracea seeds (T4-Po). Control group received normal saline. Levothyroxine (100µg/kg/day, i.p.) was administered to three other groups for 4 weeks. Valsartan (8 mg/kg/day, orally) and Po seeds extract (400 mg/kg/day, orally) were administered during the last two weeks of treatment period. At the end of the experiment, echocardiographic and hemodynamic parameters were measured and serum free T4, T3, and T4 were measured.
Results: Administration of T4 for 4 weeks significantly increased serum free T4 levels in T4 group but elevations of free T4 levels in T4–Val group were not significant. Free T4 level decreased in T4–Po (p<0.01) compared to T4 group. Heart rate (HR), heart weight (HW), and left ventricular systolic pressure (LVSP) were significantly increased in T4 group compared to control group while these parameters in the other groups were not significantly different from those of control group. The reduction in HR, HW, and LVSP were more prominent in T4-Po group. Ejection fraction (EF) and fraction shortening (FS) were insignificantly decreased in T4 group compared to control group.
Conclusion: These results showed that treatment of hyperthyroid rats with P. oleracea seeds extract was more effective than valsartan in reducing cardiac changes induced by levothyroxine.


Main Subjects

Agyare C, Baiden E, Apenteng JA, Boakye Y, Adu-Amoah L. 2015. Anti-infective and Anti-inflammatory Properties of Portulaca oleracea L. Don J Med Plant Res, 2: 1-6.
Al-Sheddi ES, Farshori NN, Al-Oqail MM, Musarrat J, Al-Khedhairy AA, Siddiqui MA. 2015. Portulaca oleracea seed oil exerts cytotoxic effects on human liver cancer (HepG2) and human lung cancer (A-549) cell lines. Asian Pac J Cancer Prev, 16: 3383-7.
Araujo A, Diniz G, Seibel F, Branchini G, Ribeiro M, Brum I, Khaper N, Barreto-Chaves M, Belló-Klein A. 2011. Reactive oxygen and nitrogen species balance in the determination of thyroid hormones-induced cardiac hypertrophy mediated by renin–angiotensin system. Molecular and cellular endocrinology, 333: 78-84.
Araujo A, Ribeiro M, Enzveiler A, Schenkel P, Fernandes T, Partata W, Irigoyen M, Llesuy S, Belló-Klein A. 2006. Myocardial antioxidant enzyme activities and concentration and glutathione metabolism in experimental hyperthyroidism. Molecular and cellular endocrinology, 249: 133-139.
Araujo A, Schenkel P, Enzveiler A, Fernandes T, Partata W, Llesuy S, Ribeiro M, Khaper N, Singal P, Bello-Klein A. 2008. The role of redox signaling in cardiac hypertrophy induced by experimental hyperthyroidism. Journal of Molecular Endocrinology, 41: 423-430.
Asahi T, Shimabukuro M, Oshiro Y, Yoshida H, Takasu N. 2001. Cilazapril prevents cardiac hypertrophy and postischemic myocardial dysfunction in hyperthyroid rats. Thyroid, 11: 1009-1015.
Askari VR, Rezaee SA, Abnous K, Iranshahi M, Boskabady MH. 2016. The influence of hydro-ethanolic extract of Portulaca oleracea L. on Th 1/Th 2 balance in isolated human lymphocytes. J Ethnopharmacol, 194: 1112-1121.
Barreto-Chaves MLM, Carrillo-Sepúlveda MA, Carneiro-Ramos MS, Gomes DA, Diniz GP. 2010. The crosstalk between thyroid hormones and the Renin–Angiotensin System. Vascul Pharmacol, 52: 166-170.
Basset A, Blanc J, Elghozi J. 2000. Contribution of the renin-angiotensin system to blood pressure variability in hyperthyroid rats. Arch Mal Coeur Vaiss, 93: 905-910.
Basset A, Blanc J, Messas E, Hagège A, Elghozi J-L. 2001. Renin-angiotensin system contribution to cardiac hypertrophy in experimental hyperthyroidism: an echocardiographic study. J Cardiovasc Pharmacol, 37: 163-172.
Bednarek J, Wysocki H, Sowiñski J. 2005. Oxidative stress peripheral parameters in Graves' disease: the effect of methimazole treatment in patients with and without infiltrative ophthalmopathy. Clin Biochem, 38: 13-18.
Boskabady MH, Hashemzehi M, Khazdair MR, Askari VR. 2016. Hydro-ethanolic Extract of Portulaca oleracea Affects Betaadrenoceptors of Guinea Pig Tracheal Smooth Muscle. Iran J Pharm Res, 15: 867.
Chan K, Islam M, Kamil M, et al. 2000. The analgesic and anti-inflammatory effects of Portulaca oleracea L. subsp. sativa (Haw.) Celak. J Ethnopharmacol, 73: 445-451.
Chen B, Zhou H, Zhao W, Zhou W, Yuan Q, Yang G. 2012. Effects of aqueous extract of Portulaca oleracea L. on oxidative stress and liver, spleen leptin, PARα and FAS mRNA expression in high-fat diet induced mice. Mol Biol Rep, 39: 7981-7988.
Choi G-P, Chung B-H, Lee D-I, Lee H-Y, Lee J-H, Kim J-D. 2002. Screening of inhibitory activities on angiotensin converting enzyme from medicinal plants. Korean Journal of Medicinal Crop Science, 10: 399-402.
Danzi S, Klein I. 2012. Thyroid hormone and the cardiovascular system. Med Clin North Am, 96: 257-268.
Danzi S, Klein I. 2014. Thyroid disease and the cardiovascular system. Endocrinol Metab Clin North Am, 43: 517-528.
De Luise M, Harker M. 1989. Skeletal muscle metabolism: effect of age, obesity, thyroid and nutritional status. Horm Metab Res, 21: 410-415.
Dkhil MA, Moniem AEA, Al-Quraishy S, Saleh RA. 2011. Antioxidant effect of purslane (Portulaca oleracea) and its mechanism of action. Journal of Medicinal Plants Research, 5: 1589-1593.
El-Sayed M-IK. 2011. Effects of Portulaca oleracea L. seeds in treatment of type-2 diabetes mellitus patients as adjunctive and alternative therapy. J Ethnopharmacol 137: 643-651
Fazio S, Palmieri EA, Lombardi G, Biondi B.2004. Effects of thyroid hormone on the cardiovascular system. Recent Prog Horm Res, 59: 31-50.
Gai Guo LY, Fan S, Jing S, Yan L-J. 2016. Antioxidant and Antiproliferative Activities of Purslane Seed Oil. J Hypertens: open access, 5
Grais IM, Sowers JR. 2014. Thyroid and the heart. The American journal of medicine, 127:691-698.
Guerra LN, de Molina MdCR, Miler EA, Moiguer S, Karner M, Burdman JA. 2005. Antioxidants and methimazole in the treatment of Graves' disease: effect on urinary malondialdehyde levels. Clinica chimica acta, 352: 115-120.
Hajzadeh M, Rakhshandeh H, Esmaeilizadeh M, Ghorbani A. 2004. Analgesic and antiinflammatory effects of Portolaca oleracea extracts in mice & rat. Faslnamahi Kumish, 5: 113-120.
Hashemzehi M, Khazdair M, Kiyanmehr M, Askari V, Boskabady M. 2016. Portulaca olerace Affects Muscarinic Receptors of Guinea Pig Tracheal Smooth Muscle. Indian J Pharm Sci, 78: 388-394.
Hu LW, Benvenuti LA, Liberti EA, Carneiro-Ramos MS, Barreto-Chaves MLM. 2003. Thyroxine-induced cardiac hypertrophy: influence of adrenergic nervous system versus renin-angiotensin system on myocyte remodeling. Am J Physiol Regul Integr Comp Physiol, 285: R1473-R1480.
Jabbar A, Pingitore A, Pearce SH, Zaman A, Iervasi G, Razvi S. 2017. Thyroid hormones and cardiovascular disease. Nat Rev Cardiol, 14: 39-55.
Kaveh M, Eidi A, Neamati A, Boskabady MH. 2017. Modulation of lung inflammation and immune markers in asthmatic rats treated by Portulaca oleracea. Avicenna J Phytomed: 1-11.
Kim BH, Im Cho K, Kim SM, Kim J-Y, Choi BG, Kang JH, Jeon YK, Kim SS, Kim S-J, Kim YK. 2012. Irbesartan prevents myocardial remodeling in experimental thyrotoxic cardiomyopathy. Endocrine journal, 59: 919-929.
Kobori H, Ichihara A, Suzuki H, Takenaka T, Miyashita Y, Hayashi M, Saruta T. 1997. Role of the renin-angiotensin system in cardiac hypertrophy induced in rats by hyperthyroidism. American Journal of Physiology-Heart and Circulatory Physiology, 273: H593-H599.
Lee AS, Kim JS, Lee YJ, Kang DG, Lee HS. 2012a. Anti-TNF-α activity of Portulaca oleracea in vascular endothelial cells. Int J Mol Sci, 13: 5628-5644.
Lee AS, Lee YJ, Lee SM, Yoon JJ, Kim JS, Kang DG, Lee HS. 2012b. Portulaca oleracea ameliorates diabetic vascular inflammation and endothelial dysfunction in db/db mice. J Evid Based Complementary Altern Med.
Lim Y, Quah E.2007. Antioxidant properties of different cultivars of Portulaca oleracea. Food Chem, 103: 734-740.
Liu L, Howe P, Zhou Y-F, Xu Z-Q, Hocart C, Zhang R. 2000. Fatty acids and β-carotene in Australian purslane (Portulaca oleracea) varieties. J Chromatogr A, 893: 207-213.
Martinez F. 2016. Thyroid hormones and heart failure. Heart Fail Rev, 21: 361-364.
Moreno JM, Gómez IR, Wangensteen R, Osuna A, Bueno P, Vargas F. 2005. Cardiac and renal antioxidant enzymes and effects of tempol in hyperthyroid rats. Am J Physiol Endocrinol Metab, 289: E776-E783.
Naeem F, Khan SH. 2013. Purslane (Portulaca oleracea L.) as phytogenic substance—A review. J Herbs Spices Med Plants, 19: 216-232.
Parry O, Marks J, Okwuasaba F. 1993. The skeletal muscle relaxant action of Portulaca oleracea: role of potassium ions. J Ethnopharmacol, 40: 187-194.
Sabri A, Samuel J-L, Marotte F, Poitevin P, Rappaport L, Levy BI. 1998. Microvasculature in angiotensin II–dependent cardiac hypertrophy in the rat. Hypertension, 32: 371-375.
Simopoulos AP, Tan DX, Manchester LC, Reiter RJ. 2005. Purslane: a plant source of omega‐3 fatty acids and melatonin. J Pineal Res, 39: 331-332.
Su L, Dai Y, Deng W, Yin Y. 2008. Renin-angiotensin system blocking agents reverse the myocardial hypertrophy in experimental hyperthyroid cardiomyopathy via altering intracellular calcium handling. Zhonghua Xin Xue Guan Bing Za Zhi, 36: 744-749.
Vargas-Uricoechea H, Sierra-Torres CH. 2014. Thyroid hormones and the heart. Horm Mol Biol Clin Investig, 18: 15-26.
Wang W-Y, Gu L-M, Dong L-W, Wang X-L, Ling C-Q, Li M.2007. Protective effect of Portulaca oleracea extracts on hypoxic nerve tissue and its mechanism. Asia Pac J Clin Nutr 16: 227-233.
Wang X, Wang W, Cao Y, Ma A. 2013. Ang II receptor expression and effect of Ang II receptor blockade in thyrotoxic rat myocardium. Eur Rev Med Pharmacol Sci, 17: 2619-2627.
Yang Z, Liu C, Xiang L, Zheng Y. 2009. Phenolic alkaloids as a new class of antioxidants in Portulaca oleracea. Phytother Res, 23: 1032-1035.
Yuan-cui X.2011. Effects of Purslane extract on blood pressure and serum lipid in a rats model of insulin resistance. Chinese Journal of Hospital Pharmacy, 20: 003.
Zhou Y-X, Xin H-L, Rahman K, Wang S-J, Peng C, Zhang H. 2015. Portulaca oleracea L.: a review of phytochemistry and pharmacological effects. Biomed Res Int, 2015.
Zidan Y, Bouderbala S, Djellouli F, Lacaille-Dubois M, Bouchenak M. 2014. Portulaca oleracea reduces triglyceridemia, cholesterolemia, and improves lecithin: cholesterol acyltransferase activity in rats fed enriched-cholesterol diet. Phytomed, 21: 1504-1508.